Australian Clinical Labs Limited (ASX:ACL)
3.320
-0.030 (-0.90%)
Nov 17, 2026, 11:19 AM AEDT
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 614.35 million as of November 16, 2026. It is the 15,523rd most valuable company in the world and the 291st biggest in Australia. Its market cap has increased by 17.25% in one year.
Market Cap
614.35M
Enterprise Value
926.33M
Revenue
736.15M
Global Rank
Country Rank
#291 Australia
PE Ratio
26.93
ChartMarket Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 614.35M, a decrease of -11.00%. That is a compound annual growth rate of -2.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 614.35M | 17.03% |
| Dec 31, 2025 | 524.97M | -23.31% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 9.82B |
| Integral Diagnostics | 618.33M |
| Healius | 428.43M |
| Monash IVF Group | 292.23M |
| Identifai Genetics | 72.95M |
| Cryosite | 59.55M |
| Microba Life Sciences | 25.21M |
| Rhythm Biosciences | 23.36M |